Pricing
  1. US-listed companies
  2. Avid Bioservices, Inc.
  3. Financials
  4. Capital expenditures

Avid Bioservices, Inc. (CDMO)

Market cap
$798.9M
P/E ratio
SummaryFinancials
Period EndCapital expenditures (Million USD)YoY (%)
Apr 30, 2024-32-59.03%
Apr 30, 2023-78+37.63%
Apr 30, 2022-56+471.89%
Apr 30, 2021-10+158.76%
Apr 30, 2020-4+153.79%
Apr 30, 2019-2-50.25%
Apr 30, 2018-3+101.13%
Apr 30, 2017-2-83.90%
Apr 30, 2016-9+3.06%
Apr 30, 2015-9+1098.28%
Apr 30, 2014-1

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat